Key Financial Results - Quarter Ended 30th September 2026
- Revenue from Operations: ₹3,195.36 lakhs (Unaudited)
- Other Income: ₹0.17 lakhs
- Total Income: ₹3,195.53 lakhs
- Total Expenses: ₹2,929.08 lakhs
- Profit before exceptional items and tax: ₹266.44 lakhs
- Exceptional Items: Bad debts written off amounting to ₹9.61 lakhs
- Profit before tax: ₹256.83 lakhs
- Total Tax Expenses: ₹64.65 lakhs (Current Tax: ₹64.52 lakhs, Deferred Tax: ₹0.13 lakhs)
- Net Profit after Tax: ₹192.18 lakhs
- Earnings Per Share (Basic & Diluted): ₹0.81
Key Financial Results - Half Year Ended 30th September 2026
- Revenue from Operations: ₹7,817.04 lakhs (Unaudited)
- Other Income: ₹7.82 lakhs
- Total Income: ₹7,824.86 lakhs
- Total Expenses: ₹7,274.41 lakhs
- Profit before exceptional items and tax: ₹550.45 lakhs
- Exceptional Items: Bad debts written off amounting to ₹9.61 lakhs
- Profit before tax: ₹540.84 lakhs
- Total Tax Expenses: ₹136.36 lakhs (Current Tax: ₹136.25 lakhs, Deferred Tax: ₹0.11 lakhs)
- Net Profit after Tax: ₹404.48 lakhs
- Earnings Per Share (Basic & Diluted): ₹1.71
Comparative Financial Performance
Quarterly Comparison (30-Sep-26 vs 30-Sep-25):
- Revenue from Operations increased from ₹1,976.40 lakhs to ₹3,195.36 lakhs
- Net Profit after Tax increased from ₹183.68 lakhs to ₹192.18 lakhs
- EPS increased from ₹0.77 to ₹0.81
Half-Yearly Comparison (30-Sep-26 vs 30-Sep-25):
- Revenue from Operations increased from ₹2,691.40 lakhs to ₹7,817.04 lakhs
- Net Profit after Tax increased from ₹133.70 lakhs to ₹404.48 lakhs
- EPS increased from ₹0.56 to ₹1.71
Balance Sheet Highlights as at 30th September 2026
- Total Assets: ₹3,593.36 lakhs (Unaudited)
- Non-Current Assets: ₹237.39 lakhs
- Current Assets: ₹3,355.97 lakhs (including Inventories: ₹1,085.25 lakhs, Trade Receivables: ₹1,228.26 lakhs, Cash & Cash Equivalents: ₹173.40 lakhs)
- Total Equity: ₹3,365.92 lakhs (Equity Share Capital: ₹2,370.79 lakhs, Other Equity: ₹995.14 lakhs)
- Total Liabilities: ₹227.44 lakhs
Cash Flow Statement - Half Year Ended 30th September 2026
- Net Cash Flow from Operating Activities: (₹858.56) lakhs
- Net Cash Flow from Investing Activities: ₹0.92 lakhs
- Net Cash Flow from Financing Activities: (₹27.19) lakhs
- Net decrease in cash & cash equivalents: (₹884.83) lakhs
- Cash and Cash equivalents (Opening Balance): ₹1,058.23 lakhs
- Cash and Cash equivalents (Closing Balance): ₹173.40 lakhs
Additional Information
- The company operates in a single business segment (pharmaceuticals)
- No subsidiary/associate/joint venture entities
- Financial results prepared in accordance with Ind AS 34 "Interim Financial Reporting"
- Paid-up equity share capital remains unchanged at ₹2,370.79 lakhs (Face Value of ₹10 each)
- Board meeting commenced at 05:00 PM and concluded at 07:00 PM (IST) on 06th November 2026